C07C 261/04
Cyanamides
Official title: Cyanamides (unsubstituted cyanamide C01C3/16)
C07C261/04 (Cyanamides) appears on 90 US grants and 76 published applications in this corpus.
Search patents in C07C- Granted patents
- 90
- Published applications
- 76
- Assignees
- 65
- Inventors
- 303
- Latest grant
- 5 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 5 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 5 | 0 |
| 1996 | 2 | 0 |
| 1997 | 5 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 1 |
| 2002 | 4 | 2 |
| 2003 | 4 | 4 |
| 2004 | 3 | 2 |
| 2005 | 1 | 0 |
| 2006 | 0 | 3 |
| 2007 | 2 | 5 |
| 2008 | 2 | 2 |
| 2009 | 0 | 1 |
| 2010 | 1 | 5 |
| 2011 | 3 | 4 |
| 2012 | 2 | 2 |
| 2013 | 5 | 2 |
| 2014 | 4 | 3 |
| 2015 | 5 | 6 |
| 2016 | 1 | 3 |
| 2017 | 2 | 3 |
| 2018 | 5 | 2 |
| 2019 | 1 | 3 |
| 2020 | 3 | 4 |
| 2021 | 2 | 3 |
| 2022 | 5 | 7 |
| 2023 | 0 | 2 |
| 2024 | 1 | 3 |
| 2025 | 2 | 1 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modulators of sestrin-GATOR2 interaction and uses thereof5 Aug 2025US 12,378,263 B2Navitor Pharmaceuticals, Inc.
- Cannabinoid derivatives10 Jun 2025US 12,325,709 B2Canopy Growth Corporation
- Bicyclic compounds1 Oct 2024US 12,103,902 B2Vivace Therapeutics, Inc.
- Bicyclic compounds23 Aug 2022US 11,420,935 B2Vivace Therapeutics, Inc.
- Compositions for the treatment of pulmonary fibrosis2 Aug 2022US 11,401,245 B2Vectus Biosystems Limited
- N-(benzhydryl)cycloalkylcarboxamide derivatives as inhibitors of glycogen synthase 1 (gys1) and methods of use thereof26 Mar 2026US 2026/0085034 A1Maze Therapeutics, Inc.
- Modulators of sestrin-gator2 interaction and uses thereof26 Feb 2026US 2026/0055122 A1Navitor Pharmaceuticals, Inc.
- Electrolyte, secondary battery, and electric device15 Jan 2026US 2026/0018672 A1Contemporary Amperex Technology Co., Limited
- Dhodh inhibitors containing a carboxylic acid bioisostere27 Feb 2025US 2025/0066290 A1Immunic AG
- Organic compounds and applications thereof in organic electronic devices14 Nov 2024US 2024/0376042 A1Zhejiang Brilliant Optoelectronic Technology Co.,Ltd.
Most cited
By later US patents
- Mesogenic polycyanates and thermosets thereof123US 5,442,039 AThe Dow Chemical Company · 1995
- Mesogenic polycyanates and thermosets thereof86US 5,428,125 AThe Dow Chemical Company · 1995
- Ketone compounds and compositions for cholesterol management and related uses56US 6,699,910 B2Esperion Therapeutics, Inc. · 2004
- Ether compounds and compositions for cholesterol management and related uses35US 6,713,507 B2Esperion Therapeutics, Inc. · 2004
- Ketone compounds and compositions for cholesterol management and related uses30US 7,304,093 B2Esperion Therapeutics, Inc. · 2007